BRCA Gene Rearrangement clinical trials at UCSF
1 research study open to eligible people
A BRCA gene rearrangement is a change in the BRCA gene that can stop cells from fixing damaged DNA. UCSF is running studies that test targeted drugs and genetic checks for people with BRCA changes. UCSF is also part of an international AI registry that matches patients and tracks results.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
open to all eligible people
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
San Francisco, California and other locations
Last updated: